27 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis of tartaric acid analogues of FR258900 and their evaluation as glycogen phosphorylase inhibitors.
University Of Debrecen
Binding evaluation of fragment-based scaffolds for probing allosteric enzymes.
Universit£
In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures.
Hokuriku University
Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.
Novo Nordisk
Synthesis of and a comparative study on the inhibition of muscle and liver glycogen phosphorylases by epimeric pairs of d-gluco- and d-xylopyranosylidene-spiro-(thio)hydantoins and N-(d-glucopyranosyl) amides.
University Of Debrecen
Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads.
Applied Science University
Discovery of a series of indan carboxylic acid glycogen phosphorylase inhibitors.
Astrazeneca
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residues.
Glaxosmithkline
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups.
Glaxosmithkline
Synthesis and pharmacological evaluation of bis-3-(3,4-dichlorophenyl)acrylamide derivatives as glycogen phosphorylase inhibitors.
Astellas Pharma
Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors.
Glaxosmithkline
Synthesis and glycogen phosphorylase inhibitor activity of 2,3-dihydrobenzo[1,4]dioxin derivatives.
University Of Debrecen
Iminosugars as potential inhibitors of glycogenolysis: structural insights into the molecular basis of glycogen phosphorylase inhibition.
The National Hellenic Research Foundation
Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies.
Astrazeneca
Synthesis and structure-activity relationships of 3-phenyl-2-propenamides as inhibitors of glycogen phosphorylase a.
Glaxosmithkline
Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.
Sanofi-Aventis Deutschland
5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.
Pfizer
Novel 3,4-dihydroquinolin-2(1H)-one inhibitors of human glycogen phosphorylase a.
Merck Research Laboratories
Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors.
Merck Research Laboratories
Biochemical and behavioral characterization of novel methylphenidate analogs.
Mercer University
The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin.
Merck Research Laboratories
The importance of odorant conformation to the binding and activation of a representative olfactory receptor.
Columbia University